Journal of Crohns & Colitis

Scope & Guideline

Unraveling complexities of gastrointestinal health.

Introduction

Immerse yourself in the scholarly insights of Journal of Crohns & Colitis with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1873-9946
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2007 to 2024
AbbreviationJ CROHNS COLITIS / J. Crohns Colitis
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The Journal of Crohns & Colitis aims to advance the understanding and management of inflammatory bowel diseases (IBD), particularly Crohn's disease and ulcerative colitis. The journal serves as a platform for disseminating high-quality research that spans clinical, translational, and basic science relevant to IBD.
  1. Clinical Research and Trials:
    The journal publishes findings from clinical trials and observational studies that explore the efficacy and safety of various treatment modalities, including biologics and small molecules.
  2. Pathophysiology and Disease Mechanisms:
    Research focusing on the underlying mechanisms of IBD, including genetic, immunological, and microbiological factors that contribute to disease onset and progression.
  3. Diagnostic Innovations:
    Studies on new diagnostic tools, such as imaging techniques and biomarkers, aimed at improving early detection and disease monitoring.
  4. Nutritional and Dietary Interventions:
    Exploration of how dietary patterns and nutritional interventions influence disease activity and patient outcomes in IBD.
  5. Quality of Life and Patient-Centered Care:
    Research addressing the psychosocial aspects of IBD, including quality of life, mental health, and the impact of the disease on daily living.
  6. Epidemiology and Health Services Research:
    Studies that investigate the epidemiology of IBD, healthcare utilization, and disparities in access to treatment.
Recent publications in the Journal of Crohns & Colitis reflect emerging trends and themes that highlight the evolving landscape of research in inflammatory bowel disease. These areas are gaining traction and are likely to shape future studies.
  1. Microbiome Research:
    There is a notable increase in studies exploring the gut microbiota's role in IBD pathogenesis, treatment response, and disease management, indicating a shift towards personalized medicine approaches.
  2. Biologic and Small Molecule Therapies:
    Research on newer biologics and JAK inhibitors is on the rise, reflecting their growing importance in treatment protocols for IBD, particularly in refractory cases.
  3. Digital Health and Telemedicine:
    The integration of digital health tools and telemedicine in managing IBD has gained momentum, especially in light of the COVID-19 pandemic, highlighting patient-centered approaches to care.
  4. Real-World Evidence Studies:
    An increasing number of publications are focused on real-world data and observational studies to assess the effectiveness and safety of treatments in diverse patient populations.
  5. Patient-Reported Outcomes and Quality of Life:
    There is a growing emphasis on understanding the patient's perspective, including the impact of IBD on quality of life and mental health, as well as the importance of shared decision-making in treatment.

Declining or Waning

While the Journal of Crohns & Colitis has consistently focused on advancing research in various aspects of inflammatory bowel disease, certain themes appear to be declining in prominence based on recent publications.
  1. Traditional Pharmacotherapy:
    Research on older pharmacological treatments, such as 5-aminosalicylic acids and thiopurines, has decreased in frequency, likely due to the increasing focus on biologics and novel therapies.
  2. Surgical Approaches:
    While surgical management remains important, the volume of studies solely focused on surgical techniques without integration into broader treatment paradigms has diminished, as there is a shift towards understanding IBD as a chronic disease needing multidisciplinary management.
  3. Animal Models of IBD:
    The reliance on animal models for studying IBD mechanisms may be waning as there is a growing emphasis on human-derived data and translational research that directly informs clinical practice.

Similar Journals

Intestinal Research

Connecting Researchers to Transform Intestinal Health
Publisher: KOREAN ASSOC STUDY INTESTINAL DISEASESISSN: 1598-9100Frequency: 4 issues/year

Intestinal Research is an influential open-access journal dedicated to advancing knowledge in the field of gastroenterology. Published by the Korean Association for the Study of Intestinal Diseases, this journal has been providing valuable insights into intestinal health since its inception in 2003. With an impressive impact factor and a current ranking of Q2 in the gastroenterology category, it is recognized among the top journals in its field, achieving a remarkable 82nd percentile in Scopus rankings. Based in South Korea, the journal's mission is to facilitate research and discussions on intestinal diseases, pathophysiology, innovative treatments, and advancements in care practices. By offering open access, Intestinal Research ensures that critical findings are readily available to researchers, healthcare professionals, and students alike, fostering global collaboration and sharing of knowledge. The journal accepts contributions that reflect the latest developments and foster deep understanding within the intestinal disease research community.

Nature Reviews Gastroenterology & Hepatology

Leading Insights in Gastroenterology & Hepatology
Publisher: NATURE PORTFOLIOISSN: 1759-5045Frequency: 12 issues/year

Nature Reviews Gastroenterology & Hepatology is a premier academic journal published by NATURE PORTFOLIO, specializing in the vital fields of gastroenterology and hepatology. With an impressive impact factor and categorized in Q1 for both disciplines, this journal ranks at the top of its field, with Scopus rankings placing it in the 99th percentile for gastroenterology and hepatology. The journal aims to provide critical reviews that synthesize the latest research findings, clinical practices, and breakthroughs, catering to researchers, healthcare professionals, and students alike. With its wide-ranging access options, it promotes the dissemination of knowledge essential for advancements in understanding digestive and liver disorders. The journal has been committed to academic excellence since its convergence in 2009, continuing to shape the future of gastroenterological and hepatological research through rigorous peer-reviewed content.

Frontline Gastroenterology

Championing Excellence in Gastroenterological Research
Publisher: BMJ PUBLISHING GROUPISSN: 2041-4137Frequency: 4 issues/year

Frontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.

DISEASES OF THE COLON & RECTUM

Your Gateway to Colorectal Research Excellence
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0012-3706Frequency: 12 issues/year

DISEASES OF THE COLON & RECTUM, published by Lippincott Williams & Wilkins, stands as a critical resource in the field of gastroenterology, focusing on the comprehensive study and management of colorectal diseases. With an ISSN of 0012-3706 and an E-ISSN of 1530-0358, this journal serves a diverse audience, including researchers, clinicians, and students interested in the latest advancements in this vital area of medicine. Recognized for its quality, it holds a Q2 ranking in both Gastroenterology and Miscellaneous Medicine categories for 2023 and is positioned at the 58th percentile within its Scopus rank. Since its inception in 1958, the journal has dedicated itself to disseminating original research, reviews, and clinical studies, providing a platform for sharing innovative findings that drive the field forward. While it is not an open access journal, its content remains pivotal for professionals looking to stay apprised of evidence-based practices and emerging trends in colorectal health. With ongoing contributions expected until 2024, DISEASES OF THE COLON & RECTUM continues to be an indispensable source of knowledge for anyone engaged in the intricacies of digestive health.

Gastroenterology Research and Practice

Elevating Standards in Gastrointestinal Research
Publisher: HINDAWI LTDISSN: 1687-6121Frequency:

Gastroenterology Research and Practice is a leading Open Access journal dedicated to advancing the field of gastroenterology and hepatology. Published by HINDAWI LTD, this journal offers a platform for researchers, clinicians, and healthcare professionals to share their findings and insights on cutting-edge topics in digestive health. With an ISSN of 1687-6121 and an E-ISSN of 1687-630X, it has established its significance within the academic community, evidenced by its ranking in the 2023 Scopus metrics, where it is positioned in the third quartile for both gastroenterology and hepatology disciplines. The journal is recognized for disseminating high-quality, peer-reviewed articles that contribute to the understanding of gastrointestinal disorders, therapeutic advancements, and innovative practices. Since its inception as an Open Access journal in 2008, Gastroenterology Research and Practice has removed barriers to access, ensuring that vital research reaches a global audience. This ongoing commitment to increasing accessibility, alongside its continuous publication from 2009 to 2024, underscores its importance as a resource for the academic and clinical communities striving to improve patient outcomes in digestive diseases.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Illuminating the Complexities of Gastrointestinal Diseases
Publisher: TAYLOR & FRANCIS LTDISSN: 0036-5521Frequency: 12 issues/year

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, published by Taylor & Francis Ltd, is a leading journal in the field of gastroenterology, dedicated to advancing clinical and experimental research related to digestive health. With an ISSN of 0036-5521 and an E-ISSN of 1502-7708, this journal provides a platform for high-quality research that addresses the complexities of gastrointestinal diseases. Since its inception in 1966, the journal has consistently contributed valuable insights and is currently categorized in the Q2 quartile of gastroenterology journals, reflecting its impact and relevance in the field, with a Scopus rank of 87 out of 167 in Medicine - Gastroenterology. Researchers and practitioners are encouraged to explore the journal's archives to enhance their understanding and stay abreast of innovative strategies for managing gastrointestinal disorders. The SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY remains a crucial resource for those committed to improving patient outcomes through rigorous scientific inquiry and the sharing of impactful findings.

Gastroenterology Research

Pioneering insights into gastrointestinal diseases and treatments.
Publisher: ELMER PRESS INCISSN: 1918-2805Frequency: 6 issues/year

Gastroenterology Research is a prominent scholarly journal dedicated to advancing the field of gastroenterology. Published by ELMER PRESS INC, this journal serves as a vital platform for disseminating innovative research, clinical findings, and comprehensive reviews that explore the complexities of the gastrointestinal system. With an ISSN of 1918-2805 and an E-ISSN of 1918-2813, it reaches a global audience of researchers, healthcare professionals, and students eager to contribute to or keep abreast of the latest developments in gastroenterology. Though details such as the H-index and Scopus rankings are currently unspecified, the journal's commitment to quality and impact in the medical research community is evident. Gastroenterology Research aims to foster collaboration and knowledge sharing among experts, ultimately improving patient care and outcomes within this critical area of health science. Explore the cutting-edge studies published within its pages and engage with a community passionate about the investigation and treatment of gastrointestinal diseases.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Connecting researchers and clinicians for better outcomes.
Publisher: ARAN EDICIONES, S AISSN: 1130-0108Frequency: 12 issues/year

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.

Translational Gastroenterology and Hepatology

Connecting Research to Real-World Solutions in Hepatology.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Pioneering research for a healthier digestive future.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.